- 2009-07-02 Prasco and Axcan Pharma Sign a Distribution and Supply Agreement for Authorized Generic Versions of URSO Forte® Scored and URSO 250® (Ursodiol Tablets, USP)
- 2009-07-02 Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Investment
- 2009-07-01 Biogen Idec and Acorda Therapeutics Announce Collaboration Agreement to Develop and Commercialize MS Therapy Fampridine-SR in Markets Outside the U.S.
- 2009-07-01 CombinatoRx and Neuromed Sign Merger Agreement
- 2009-07-01 Fate Therapeutics Granted Exclusive License By The Regents Of The University Of California To Stem Cell Modulators For Osteo-Regeneration
- 2009-07-01 Morphotek®, Inc. Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and Infectious Disease
- 2009-07-01 Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement
- 2009-06-30 Catalyst Biosciences And Wyeth Pharmaceuticals Announce Worldwide Collaboration
- 2009-06-30 Optimata to Collaborate with Teva Pharmaceutical Industries Ltd. on Clinical Development of Solid Tumor Cancer Drugs
- 2009-06-30 Medarex to Receive Milestone Payment for the Approval of Ilaris for the Treatment of Cryopyrin-Associated Periodic Syndrome
